About the Conference
The field of valvular heart disease continues to grow and evolve with the introduction of new technologies for diagnostic tools, pharmacologic drugs for the management of symptoms, as well as new devices including valves for surgery. There is a need for education to have appropriate patient selection, procedure selection, and valve selection for optimal patient outcomes in valvular heart disease.
This conference is designed for cardiothoracic surgeons, primary cardiologists, interventional cardiologists, anesthesiologists, nurses, technicians, nurse practitioners, perfusionists, cardiac imaging specialists, and other healthcare providers of cardiovascular teams.
At the conclusion of this program, the attendee will be better able to:
- Evaluate therapeutic options for patients with heart disease and related conditions
- Incorporate information from clinical trials and evidence-based medicine to guide management of patients with heart disease
- Utilize data and technology in the care of patients with heart disease
- Discuss the role of a multispecialty team in the management of heart disease
Method of Participation
This two day conference will use multiple methods of participation to engage attendees and enhance the learning process through a unique cardiology and surgery collaboration in live surgeries, challenging case studies, didactic lectures, and intense debates on controversial areas of managing valvular heart disease and congestive heart failure.
The Foundation for Advanced Cardiovascular Education and Training (FACET), Provider # 0007001, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Foundation for Advanced Cardiovascular Education and Training (FACET) designates this live activity for 20 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
20 hours of CEP Nursing Credit will be provided.
More information to follow.